Page last updated: 2024-10-25

cinoxacin and Bordetella pertussis Infection, Respiratory

cinoxacin has been researched along with Bordetella pertussis Infection, Respiratory in 1 studies

Cinoxacin: Synthetic antimicrobial related to OXOLINIC ACID and NALIDIXIC ACID and used in URINARY TRACT INFECTIONS.
cinoxacin : A member of the class of cinnolines that is 6,7-methylenedioxycinnolin-4(1H)-one bearing an ethyl group at position 1 and a carboxylic acid group at position 3. An analogue of oxolinic acid, it has similar antibacterial actions. It was formerly used for the treatment of urinary tract infections.

Research Excerpts

ExcerptRelevanceReference
"Cinoxacin was only moderately active (MIC90 4."1.27Susceptibility of Bordetella pertussis to five quinolone antimicrobic drugs. ( Appleman, ME; Gaines, JK; Hadfield, TL; Winn, RE, 1987)

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19901 (100.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Appleman, ME1
Hadfield, TL1
Gaines, JK1
Winn, RE1

Other Studies

1 other study available for cinoxacin and Bordetella pertussis Infection, Respiratory

ArticleYear
Susceptibility of Bordetella pertussis to five quinolone antimicrobic drugs.
    Diagnostic microbiology and infectious disease, 1987, Volume: 8, Issue:2

    Topics: Anti-Bacterial Agents; Bordetella pertussis; Cinoxacin; Ciprofloxacin; Drug Resistance, Microbial; E

1987